pubmed-article:14686722 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:14686722 | lifeskim:mentions | umls-concept:C0023911 | lld:lifeskim |
pubmed-article:14686722 | lifeskim:mentions | umls-concept:C0566602 | lld:lifeskim |
pubmed-article:14686722 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
pubmed-article:14686722 | lifeskim:mentions | umls-concept:C0036273 | lld:lifeskim |
pubmed-article:14686722 | pubmed:issue | 11 | lld:pubmed |
pubmed-article:14686722 | pubmed:dateCreated | 2003-12-22 | lld:pubmed |
pubmed-article:14686722 | pubmed:abstractText | Primary sclerosing cholangitis (PSC) is the most common indication for liver transplantation in the Nordic countries. Because these patients are difficult to evaluate with regard to timing of liver transplantation, it is important to establish predictors of post-transplant survival. | lld:pubmed |
pubmed-article:14686722 | pubmed:language | eng | lld:pubmed |
pubmed-article:14686722 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:14686722 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:14686722 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:14686722 | pubmed:month | Nov | lld:pubmed |
pubmed-article:14686722 | pubmed:issn | 0036-5521 | lld:pubmed |
pubmed-article:14686722 | pubmed:author | pubmed-author:SchrumpfEE | lld:pubmed |
pubmed-article:14686722 | pubmed:author | pubmed-author:HansenBB | lld:pubmed |
pubmed-article:14686722 | pubmed:author | pubmed-author:OksanenAA | lld:pubmed |
pubmed-article:14686722 | pubmed:author | pubmed-author:KirkegaardPP | lld:pubmed |
pubmed-article:14686722 | pubmed:author | pubmed-author:FrimanSS | lld:pubmed |
pubmed-article:14686722 | pubmed:author | pubmed-author:BäckmanLL | lld:pubmed |
pubmed-article:14686722 | pubmed:author | pubmed-author:BjøroKK | lld:pubmed |
pubmed-article:14686722 | pubmed:author | pubmed-author:HöckerstedtKK | lld:pubmed |
pubmed-article:14686722 | pubmed:author | pubmed-author:IsoniemiHH | lld:pubmed |
pubmed-article:14686722 | pubmed:author | pubmed-author:MäkisaloHH | lld:pubmed |
pubmed-article:14686722 | pubmed:author | pubmed-author:OlaussonMM | lld:pubmed |
pubmed-article:14686722 | pubmed:author | pubmed-author:EriczonB GBG | lld:pubmed |
pubmed-article:14686722 | pubmed:author | pubmed-author:BrooméUU | lld:pubmed |
pubmed-article:14686722 | pubmed:author | pubmed-author:BrandsaeterBB | lld:pubmed |
pubmed-article:14686722 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:14686722 | pubmed:volume | 38 | lld:pubmed |
pubmed-article:14686722 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:14686722 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:14686722 | pubmed:pagination | 1176-83 | lld:pubmed |
pubmed-article:14686722 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:14686722 | pubmed:meshHeading | pubmed-meshheading:14686722... | lld:pubmed |
pubmed-article:14686722 | pubmed:meshHeading | pubmed-meshheading:14686722... | lld:pubmed |
pubmed-article:14686722 | pubmed:meshHeading | pubmed-meshheading:14686722... | lld:pubmed |
pubmed-article:14686722 | pubmed:meshHeading | pubmed-meshheading:14686722... | lld:pubmed |
pubmed-article:14686722 | pubmed:meshHeading | pubmed-meshheading:14686722... | lld:pubmed |
pubmed-article:14686722 | pubmed:meshHeading | pubmed-meshheading:14686722... | lld:pubmed |
pubmed-article:14686722 | pubmed:meshHeading | pubmed-meshheading:14686722... | lld:pubmed |
pubmed-article:14686722 | pubmed:meshHeading | pubmed-meshheading:14686722... | lld:pubmed |
pubmed-article:14686722 | pubmed:meshHeading | pubmed-meshheading:14686722... | lld:pubmed |
pubmed-article:14686722 | pubmed:meshHeading | pubmed-meshheading:14686722... | lld:pubmed |
pubmed-article:14686722 | pubmed:meshHeading | pubmed-meshheading:14686722... | lld:pubmed |
pubmed-article:14686722 | pubmed:meshHeading | pubmed-meshheading:14686722... | lld:pubmed |
pubmed-article:14686722 | pubmed:meshHeading | pubmed-meshheading:14686722... | lld:pubmed |
pubmed-article:14686722 | pubmed:meshHeading | pubmed-meshheading:14686722... | lld:pubmed |
pubmed-article:14686722 | pubmed:meshHeading | pubmed-meshheading:14686722... | lld:pubmed |
pubmed-article:14686722 | pubmed:meshHeading | pubmed-meshheading:14686722... | lld:pubmed |
pubmed-article:14686722 | pubmed:meshHeading | pubmed-meshheading:14686722... | lld:pubmed |
pubmed-article:14686722 | pubmed:meshHeading | pubmed-meshheading:14686722... | lld:pubmed |
pubmed-article:14686722 | pubmed:meshHeading | pubmed-meshheading:14686722... | lld:pubmed |
pubmed-article:14686722 | pubmed:meshHeading | pubmed-meshheading:14686722... | lld:pubmed |
pubmed-article:14686722 | pubmed:meshHeading | pubmed-meshheading:14686722... | lld:pubmed |
pubmed-article:14686722 | pubmed:meshHeading | pubmed-meshheading:14686722... | lld:pubmed |
pubmed-article:14686722 | pubmed:meshHeading | pubmed-meshheading:14686722... | lld:pubmed |
pubmed-article:14686722 | pubmed:meshHeading | pubmed-meshheading:14686722... | lld:pubmed |
pubmed-article:14686722 | pubmed:year | 2003 | lld:pubmed |
pubmed-article:14686722 | pubmed:articleTitle | Outcome following liver transplantation for primary sclerosing cholangitis in the Nordic countries. | lld:pubmed |
pubmed-article:14686722 | pubmed:affiliation | Dept. of Medicine, Rikshospitalet, Oslo, Norway. bjorn.brandsaeter@rikshospitalet.no | lld:pubmed |
pubmed-article:14686722 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:14686722 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:14686722 | pubmed:publicationType | Multicenter Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14686722 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14686722 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14686722 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14686722 | lld:pubmed |